Free shipping on all orders over $ 500

Iladatuzumab vedotin

Cat. No. M24847

All AbMole products are for research use only, cannot be used for human consumption.

Iladatuzumab vedotin Structure
Synonym:

DCDS-0780A

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Quality Control & Documentation
Biological Activity

Iladatuzumab vedotin (DCDS-0780A) is an antibody–drug conjugate (ADC) containing humanized IgG1 anti-human CD79B monoclonal antibody conjugated to MMAE via a protease labile linker. Iladatuzumab vedotin uses novel THIOMAB technology (TDC) to consistently conjugate two MMAE molecules per antibody using engineered cysteine residues. Iladatuzumab vedotin has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research.

Chemical Information
CAS Number 1906205-77-3
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Anthony Markham. Drugs. Tisotumab Vedotin: First Approval

[2] Emma D Deeks. Drugs. Disitamab Vedotin: First Approval

[3] Emma D Deeks. Drugs. Polatuzumab Vedotin: First Global Approval

[4] Carrie Van Der Weyden, et al. Expert Rev Hematol. Brentuximab vedotin in T-cell lymphoma

[5] Craig H Moskowitz, et al. Lancet. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Related Drug-Linker Conjugates for ADC Products
MC-SN38 

MC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC).
DM4-SMCC 

DM4-SMCC is a agent-linker conjugate for ADC with antitumor activity by using DM4 (an antitubulin agent), linked via the non-cleavable SMCC linker.
Lys-SMCC-DM1

Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) is a agent-linker conjugates for ADC that can inhibit tubulin polymerization.
Doxorubicin-SMCC 

Doxorubicin-SMCC is a agent-linker conjugate for ADC.
Mal-PEG4-VC-PAB-DMEA-PNU-159682 

Mal-PEG4-VC-PAB-DMEA-PNU-159682, a agent-linker conjugate for ADC, consists the ADC linker Mal-PEG4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682.
  Catalog
Abmole Inhibitor Catalog




Keywords: Iladatuzumab vedotin, DCDS-0780A supplier, Drug-Linker Conjugates for ADC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.


 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.